tykhr
sign in
free sign up
Liminatus Pharma, Inc. Class A Common Stock
Biotechnology
Healthcare
LIMN
26.01 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.48
52 week high
26.67
high
1.74
52 week low
0.00
low
1.41
growth
-79.10 %
previous Close
1.43
P/E ratio
market cap
div yield
0
usd
Mar 2025
qoq
revenue
0.00 %
net incoming
-255
0.00 %
eps
0.00 %
0.00 %
eps surprise
0.00 %
net profit margin
-25500.00 %
0.00 %
operating incoming
-255
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top